CHITOSAN AS A NASAL DELIVERY SYSTEM - EVALUATION OF INSULIN ABSORPTION ENHANCEMENT AND EFFECT ON NASAL MEMBRANE INTEGRITY USING RAT MODELS

Citation
Tj. Aspden et al., CHITOSAN AS A NASAL DELIVERY SYSTEM - EVALUATION OF INSULIN ABSORPTION ENHANCEMENT AND EFFECT ON NASAL MEMBRANE INTEGRITY USING RAT MODELS, European journal of pharmaceutical sciences, 4(1), 1996, pp. 23-31
Citations number
25
Categorie Soggetti
Pharmacology & Pharmacy
ISSN journal
09280987
Volume
4
Issue
1
Year of publication
1996
Pages
23 - 31
Database
ISI
SICI code
0928-0987(1996)4:1<23:CAANDS>2.0.ZU;2-4
Abstract
The ability of a range of chitosans to act as nasal peptide absorption promoter systems was investigated using the rat nasal absorption mode l described by Illum et al. (1989). The systemic absorption of insulin was monitored indirectly by measuring arterial blood glucose levels. All five chitosans evaluated produced clinically relevant levels of in sulin in the blood. The effect on nasal epithelial membranes of circul ating 0.25% w/v chitosan solutions, was investigated using the rat nas al perfusion method. Perfusate samples were assayed for total protein content, the membrane-bound enzyme 5'-nucleotidase (5'ND) and the cyto solic enzyme lactate dehydrogenase (LDH). All the chitosans tested cau sed minimal membrane and cellular damage when compared to the membrane destruction caused by perfusing a 1% w/v Laureth 9 solution. The time dependent increase in perfusate protein content observed was suggeste d to be due to the interaction of chitosan with mucin on the membrane surface.